Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Amaral

Showing results (1-10 of 307) with videos related to

Pageof 31
Sort By:
JAPCA|April 1, 1988
Including uncertainty in assessments of sulfur oxide health risksD Amaral
AMB : Revista Da Associacao Medica Brasileira|April 1, 1972
[Alfonso Splendore. His contribution to parasitology]A D Amaral
Pediatric Pulmonology|March 15, 2005
Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis?Margarida D Amaral
Journal of Inherited Metabolic Disease|June 10, 2006
Therapy through chaperones: sense or antisense? Cystic fibrosis as a model diseaseMargarida D Amaral
Journal of Internal Medicine|October 1, 2014
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patientsM D Amaral
European Journal of Medicinal Chemistry|November 16, 2020
How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranosticsMargarida D Amaral
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
Introduction to section III: resources for CFTR researchMargarida D Amaral
Current Drug Targets|November 3, 2010
Targeting CFTR: how to treat cystic fibrosis by CFTR-repairing therapiesMargarida D Amaral
Journal of Molecular Neuroscience : MN|May 6, 2004
CFTR and chaperones: processing and degradationMargarida D Amaral
The Journal of Physiology|September 7, 2022
Using the genome to correct the ion transport defect in cystic fibrosisMargarida D Amaral
Pageof 31

Showing results (1-10 of 307) with videos related to

Sort By:
Pageof 31
JAPCA|April 1, 1988
Including uncertainty in assessments of sulfur oxide health risksD Amaral
AMB : Revista Da Associacao Medica Brasileira|April 1, 1972
[Alfonso Splendore. His contribution to parasitology]A D Amaral
Pediatric Pulmonology|March 15, 2005
Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis?Margarida D Amaral
Journal of Inherited Metabolic Disease|June 10, 2006
Therapy through chaperones: sense or antisense? Cystic fibrosis as a model diseaseMargarida D Amaral
Journal of Internal Medicine|October 1, 2014
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patientsM D Amaral
European Journal of Medicinal Chemistry|November 16, 2020
How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranosticsMargarida D Amaral
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
Introduction to section III: resources for CFTR researchMargarida D Amaral
Current Drug Targets|November 3, 2010
Targeting CFTR: how to treat cystic fibrosis by CFTR-repairing therapiesMargarida D Amaral
Journal of Molecular Neuroscience : MN|May 6, 2004
CFTR and chaperones: processing and degradationMargarida D Amaral
The Journal of Physiology|September 7, 2022
Using the genome to correct the ion transport defect in cystic fibrosisMargarida D Amaral
Pageof 31